| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 258.43M | 221.16M | 252.99M | 278.76M | 371.28M |
| Gross Profit | 10.11M | 180.10M | 196.55M | 255.08M | 344.26M |
| EBITDA | 17.48M | 9.18M | -118.30M | 46.89M | 163.91M |
| Net Income | -131.66M | -20.49M | -156.81M | -87.84M | 134.07M |
Balance Sheet | |||||
| Total Assets | 276.33M | 445.83M | 451.04M | 593.95M | 709.15M |
| Cash, Cash Equivalents and Short-Term Investments | 41.57M | 60.73M | 56.56M | 37.03M | 52.13M |
| Total Debt | 41.81M | 44.93M | 67.38M | 78.25M | 116.29M |
| Total Liabilities | 91.25M | 130.45M | 162.06M | 145.68M | 192.77M |
| Stockholders Equity | 185.76M | 316.14M | 289.62M | 448.61M | 516.83M |
Cash Flow | |||||
| Free Cash Flow | -3.83M | -19.26M | 15.57M | 17.29M | 151.89M |
| Operating Cash Flow | 29.79M | -1.91M | 55.26M | 31.74M | 165.10M |
| Investing Cash Flow | -29.30M | -15.88M | -15.06M | -14.12M | -13.75M |
| Financing Cash Flow | -20.80M | 16.14M | -19.25M | -30.54M | -119.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$430.26B | 9.80 | 29.93% | 1.45% | 8.77% | 60.69% | |
66 Neutral | HK$128.58B | 9.10 | 5.16% | 2.80% | 0.98% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | HK$1.95B | -15.63 | ― | ― | ― | ― | |
54 Neutral | HK$464.00M | 106.96 | 1.07% | ― | 7.89% | ― | |
46 Neutral | HK$958.46M | -5.92 | -44.33% | ― | 16.57% | -350.20% | |
38 Underperform | HK$44.24M | -0.15 | -177.54% | ― | -26.77% | -31.52% |